Prolastin and bone marrow failure Patient Reports February 11, 2012

Prolastin Side Effects Report #5157179-6
Prolastin side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2006. Female patient, 51 years of age, weighting 128.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Prolastin. After drug was administered, patient experienced the following side effects: bone marrow failure, lymphadenopathy, platelet count decreased, viral infection , white blood cell count decreased. Prolastin dosage: 3700 MG, TOTAL DAILY, INTRAVENOUS. Patient recovered.

Prolastin Side Effects Report #5165458-1
Prolastin side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 14, 2006. Female patient, 51 years of age, weighting 128.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Prolastin. After drug was administered, patient experienced the following side effects: bone marrow failure, lymphadenopathy, platelet count decreased, viral infection , white blood cell count decreased. Prolastin dosage: 3700 MG, TOTAL DAILY, INTRAVEOUS. Patient recovered.

Prolastin Side Effects Report #5179147-0
Prolastin side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 01, 2006. Female patient, 51 years of age, weighting 128.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Prolastin. After drug was administered, patient experienced the following side effects: bone marrow failure, lymphadenopathy, viral infection . Prolastin dosage: 3700 MG, TOTAL DAILY, INTRAVENOUS. Patient recovered.

Prolastin Side Effects Report #5195979-7
Prolastin side effect was reported by a Health Professional from UNITED STATES on Dec 14, 2006. Female patient, 51 years of age, weighting 128.0 lb, was diagnosed with alpha-1 anti-trypsin deficiency and was treated with Prolastin. After drug was administered, patient experienced the following side effects: bone marrow failure, lymphadenopathy, platelet count decreased, viral infection , white blood cell count decreased. Prolastin dosage: 3700 MG, TOTAL DAILY, INTRAVENOUS. Patient recovered.